HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ge Yan Selected Research

Neoplasm Metastasis (Metastasis)

2/2024Brucea javanica derived exosome-like nanovesicles deliver miRNAs for cancer therapy.
1/2023LncRNA BCAR4 promotes migration, invasion, and chemo-resistance by inhibiting miR-644a in breast cancer.
1/2019miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
11/2017Construction of C35 gene bait recombinants and T47D cell cDNA library.
5/2014Overexpression of B7-H3 in CD133+ colorectal cancer cells is associated with cancer progression and survival in human patients.
1/2008Lymphangiogenic and angiogenic microvessel density in human primary sporadic colorectal carcinoma.
6/2007Chromosomal alteration in Chinese sporadic colorectal carcinomas detected by comparative genomic hybridization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ge Yan Research Topics

Disease

27Neoplasms (Cancer)
05/2024 - 07/2003
8Inflammation (Inflammations)
12/2023 - 08/2010
7Neoplasm Metastasis (Metastasis)
02/2024 - 06/2007
5Breast Neoplasms (Breast Cancer)
01/2023 - 10/2010
3Mitochondrial Diseases (Mitochondrial Disease)
07/2022 - 01/2020
3Colorectal Neoplasms (Colorectal Cancer)
04/2011 - 09/2006
2Liver Neoplasms (Liver Cancer)
05/2024 - 12/2003
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
12/2023 - 10/2022
2Dermatitis
08/2023 - 01/2022
2Psoriasis (Pustulosis Palmaris et Plantaris)
08/2023 - 01/2022
2Macular Degeneration (Age-Related Maculopathy)
01/2023 - 01/2022
2Neuroinflammatory Diseases
01/2023 - 01/2022
2Leukemia
07/2022 - 12/2021
2Nervous System Diseases (Neurological Disorders)
02/2022 - 02/2019
2Carcinogenesis
03/2019 - 04/2011
2Carcinoma (Carcinomatosis)
01/2018 - 01/2017
2Stomach Neoplasms (Stomach Cancer)
01/2018 - 01/2017
2Neutropenia
01/2018 - 01/2017
2Lymphatic Metastasis
12/2015 - 05/2014
2Hepatocellular Carcinoma (Hepatoma)
01/2015 - 08/2003
2Hepatitis B
01/2015 - 04/2005
2Infections
04/2008 - 08/2003
1Alopecia (Baldness)
09/2024
1Triple Negative Breast Neoplasms
02/2024
1Wounds and Injuries (Trauma)
10/2023
1Fetal Growth Retardation (Intrauterine Growth Retardation)
09/2023
1Falciparum Malaria (Plasmodium falciparum Malaria)
12/2022
1Chronic Renal Insufficiency
11/2022
1Colitis
10/2022
1Nasopharyngeal Carcinoma
06/2022
1Immune System Diseases (Immune Disorders)
02/2022
1Bullous Pemphigoid (Pemphigoid)
01/2022
1Renal Insufficiency (Renal Failure)
01/2022
1Acute Kidney Injury (Acute Renal Failure)
01/2022
1Multiple Myeloma
01/2022
1Osteoarthritis
01/2022
1Multiple Hereditary Exostoses (Hereditary Multiple Exostoses)
11/2021
1Congenital Abnormalities (Deformity)
11/2021

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
09/2023 - 10/2010
6Proteins (Proteins, Gene)FDA Link
01/2023 - 12/2015
6Small Interfering RNA (siRNA)IBA
01/2020 - 08/2003
4Long Noncoding RNAIBA
04/2023 - 01/2019
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2022 - 04/2011
3MicroRNAs (MicroRNA)IBA
02/2024 - 01/2019
3CytokinesIBA
08/2023 - 04/2011
3Messenger RNA (mRNA)IBA
11/2021 - 09/2006
3Docetaxel (Taxotere)FDA Link
01/2020 - 01/2017
3SurvivinIBA
12/2008 - 12/2003
2Nucleic AcidsIBA
02/2024 - 01/2023
2Interleukin-17 (Interleukin 17)IBA
08/2023 - 01/2022
2N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA
01/2023 - 01/2022
2Retinaldehyde (Retinal)IBA
01/2023 - 01/2022
2InterleukinsIBA
01/2022 - 08/2010
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2020
2NF-kappa B (NF-kB)IBA
01/2020 - 07/2003
2Fluorouracil (Carac)FDA LinkGeneric
01/2018 - 01/2017
2Cisplatin (Platino)FDA LinkGeneric
01/2018 - 01/2017
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2011 - 08/2010
2Alanine Transaminase (SGPT)IBA
04/2011 - 08/2010
2DNA (Deoxyribonucleic Acid)IBA
12/2008 - 06/2007
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
09/2024
1CaspasesIBA
02/2024
1Infliximab (Remicade)FDA Link
12/2023
1PolyphenolsIBA
12/2023
1Poloxamer (Poloxamer 407)IBA
12/2023
1Imiquimod (Aldara)FDA LinkGeneric
08/2023
1Antiviral Agents (Antivirals)IBA
01/2023
1artemisinin (artemisinine)IBA
12/2022
1Aristolochic AcidsIBA
11/2022
1LycopeneIBA
11/2022
1AntioxidantsIBA
11/2022
1aristolochic acid I (aristolochic acid)IBA
11/2022
1sodium sulfate (sodium bisulfate)FDA LinkGeneric
10/2022
1Dextrans (Dextran)FDA Link
10/2022
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
07/2022
1Reactive Oxygen Species (Oxygen Radicals)IBA
07/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
07/2022
1CateninsIBA
07/2022
1muskIBA
02/2022
1musconeIBA
02/2022
1muscopyridineIBA
02/2022
1SteroidsIBA
02/2022
1Peptides (Polypeptides)IBA
02/2022
1Immunoglobulin D (IgD)IBA
01/2022
1Interleukin-22 (IL-22)IBA
01/2022
1BerberineIBA
01/2022
1CurcuminIBA
01/2022
1moniliforminIBA
12/2021
1Histone Deacetylases (Histone Deacetylase)IBA
12/2021
1Eukaryotic Initiation Factor-2 (EIF 2)IBA
11/2021

Therapy/Procedure

19Therapeutics
02/2024 - 07/2003
6Drug Therapy (Chemotherapy)
05/2024 - 01/2017
4Radiotherapy
06/2022 - 01/2017
2Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
06/2022 - 01/2018
2Chemoradiotherapy
01/2020 - 01/2018
1Microspheres (Microsphere)
05/2024
1Induction Chemotherapy
06/2022
1Aftercare (After-Treatment)
01/2022
1Osteotomy
11/2021
1Distraction Osteogenesis
11/2021